WO1992011025A3 - Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases - Google Patents
Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases Download PDFInfo
- Publication number
- WO1992011025A3 WO1992011025A3 PCT/US1991/009177 US9109177W WO9211025A3 WO 1992011025 A3 WO1992011025 A3 WO 1992011025A3 US 9109177 W US9109177 W US 9109177W WO 9211025 A3 WO9211025 A3 WO 9211025A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- malignant proliferative
- pulmonary diseases
- alpha interferon
- oral inhalation
- treat asthma
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63156590A | 1990-12-21 | 1990-12-21 | |
US63155290A | 1990-12-21 | 1990-12-21 | |
US631552 | 1990-12-21 | ||
US631565 | 1990-12-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1992011025A2 WO1992011025A2 (en) | 1992-07-09 |
WO1992011025A3 true WO1992011025A3 (en) | 1992-09-17 |
Family
ID=27091422
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1991/009177 WO1992011025A2 (en) | 1990-12-21 | 1991-12-18 | Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases |
Country Status (6)
Country | Link |
---|---|
AU (1) | AU9132091A (en) |
IE (1) | IE914444A1 (en) |
IL (1) | IL100415A0 (en) |
MX (1) | MX9102702A (en) |
PT (1) | PT99837A (en) |
WO (1) | WO1992011025A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6271206B1 (en) | 1996-09-12 | 2001-08-07 | Valentis, Inc. | Sonic nebulized nucleic acid/cationic liposome complexes and methods for pulmonary gene delivery |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0248583A2 (en) * | 1986-05-27 | 1987-12-09 | Schering Corporation | Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon |
EP0266940A1 (en) * | 1986-10-22 | 1988-05-11 | Schering Corporation | Use of recombinant human alpha interferon for the manufacture of a medicament for the treatment of AIDS virus |
WO1988009673A1 (en) * | 1987-06-02 | 1988-12-15 | Schering Corporation | Treatment of chronic type b hepatitis with a combination of recombinant human alpha and gamma interferons |
EP0351974A1 (en) * | 1988-07-05 | 1990-01-24 | Schering Corporation | Treatment of genital warts with a combination of podophyllin and recombinant DNA human alpha interferon |
EP0372809A1 (en) * | 1988-12-01 | 1990-06-13 | Schering Corporation | Medicament for the treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon |
US4959210A (en) * | 1988-11-01 | 1990-09-25 | Schering Corporation | Treatment of genital warts with a combination of liquid nitrogen and recombinant DNA human alpha interferon |
US5028422A (en) * | 1986-05-27 | 1991-07-02 | Schering Corporation | Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon |
-
1991
- 1991-12-18 PT PT99837A patent/PT99837A/en not_active Application Discontinuation
- 1991-12-18 AU AU91320/91A patent/AU9132091A/en not_active Abandoned
- 1991-12-18 IL IL100415A patent/IL100415A0/en unknown
- 1991-12-18 WO PCT/US1991/009177 patent/WO1992011025A2/en active Application Filing
- 1991-12-19 MX MX9102702A patent/MX9102702A/en unknown
- 1991-12-19 IE IE444491A patent/IE914444A1/en not_active Application Discontinuation
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0248583A2 (en) * | 1986-05-27 | 1987-12-09 | Schering Corporation | Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon |
US5028422A (en) * | 1986-05-27 | 1991-07-02 | Schering Corporation | Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon |
EP0266940A1 (en) * | 1986-10-22 | 1988-05-11 | Schering Corporation | Use of recombinant human alpha interferon for the manufacture of a medicament for the treatment of AIDS virus |
WO1988009673A1 (en) * | 1987-06-02 | 1988-12-15 | Schering Corporation | Treatment of chronic type b hepatitis with a combination of recombinant human alpha and gamma interferons |
EP0351974A1 (en) * | 1988-07-05 | 1990-01-24 | Schering Corporation | Treatment of genital warts with a combination of podophyllin and recombinant DNA human alpha interferon |
US4959210A (en) * | 1988-11-01 | 1990-09-25 | Schering Corporation | Treatment of genital warts with a combination of liquid nitrogen and recombinant DNA human alpha interferon |
EP0372809A1 (en) * | 1988-12-01 | 1990-06-13 | Schering Corporation | Medicament for the treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon |
Non-Patent Citations (1)
Title |
---|
Chemical Abstracts, vol. 101, no. 17, 22 October 1984, (Columbus, Ohio, US), V. BOCCI et al.: "Pulmonary catabolism of interferons: alveolar absorption of 125I-labeled human interferon alpha is accompanied by partial loss of biological activity", see page 539, abstract no. 149518m, & ANTIVIRAL RES. 1984, 4(4), 211-20 (cited in the application) * |
Also Published As
Publication number | Publication date |
---|---|
WO1992011025A2 (en) | 1992-07-09 |
IE914444A1 (en) | 1992-07-01 |
IL100415A0 (en) | 1992-09-06 |
AU9132091A (en) | 1992-07-22 |
MX9102702A (en) | 1992-06-01 |
PT99837A (en) | 1992-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL112459A (en) | Use of mometasone furoate in the manufacture of a medicament for treating airway passage and lung diseases | |
Sutton et al. | Use of nebulised saline and nebulised terbutaline as an adjunct to chest physiotherapy. | |
CA2146954A1 (en) | Breath activated nicotine inhalers | |
Lofdahl et al. | Differences in bronchodilating potency of salbutamol in Turbuhaler as compared with a pressurized metered-dose inhaler formulation in patients with reversible airway obstruction | |
Newhouse | Principles of aerosol therapy | |
WO1992011025A3 (en) | Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases | |
Souëf | The meaning of lung dose | |
GR3022083T3 (en) | Inhalant based on taurine | |
Brosch et al. | Anesthetic Management of the Asthmatic Patient with Special Reference to the Use of Ketamine | |
Matthys | Chlorofluorocarbon-free aerosol therapy in patients with pulmonary airflow obstruction | |
Lahdensuo | Bronchodilator effects of fenoterol and salbutamol administered by intermittent positive pressure breathing to patients with asthma or chronic obstructive bronchitis | |
Gorbach et al. | Therapeutic potentialities of rifampicin-dimexid inhalations in phthisiopulmonology. | |
Brosch et al. | Vortrag Nr. 164 ANESTHETIC MANAGEMENT OF THE ASTHMATIC PATIENT WITH SPECIAL REference TO THE USE OF KETAMINE | |
Nieminen et al. | Equivalent clinical effectiveness of old and new models of Easyhaler | |
ZA919959B (en) | Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU BB BG BR CA CS FI HU JP KP KR LK MG MW NO PL RO SD SU |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE BF BJ CF CG CH CI CM DE DK ES FR GA GB GN GR IT LU MC ML MR NL SE SN TD TG |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU BB BG BR CA CS FI HU JP KP KR LK MG MW NO PL RO SD SU |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE BF BJ CF CG CH CI CM DE DK ES FR GA GB GN GR IT LU MC ML MR NL SE SN TD TG |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |